Riverside Partners Invests in Syner-G

Choate represented Riverside Partners in its investment in Syner-G Pharma Consulting, LLC, which provides a full spectrum of chemistry, manufacturing, and controls (CMC) technical, regulatory, and compliance consulting services to pharmaceutical and biotechnology clients. Syner-G uses customized science and risk-based approaches to support the development of lifesaving and breakthrough therapeutics, and has a proven track record of success that includes support the development and filings leading to approvals of numerous INDs, IMPDs, NDAs, MAAs, post approval submissions, and other global submissions. This investment will help Syner-G accelerate its growth and reach new customers.